medigraphic.com
Colegio de Medicina Interna de México.

2008, Number 6

<< Back Next >>

Med Int Mex 2008; 24 (6)

Pre-eclampsia and oxide reduction state imbalance. Antioxidant role

Duarte MJ, Espinosa LRF, Díaz MS, Sánchez RG, Lee Eng CVE, Díaz CIA

Language: Spanish
References: 24
Page: 407-413
PDF size: 213.43 Kb.


ABSTRACT

Hypertension complicates 5 to 10% of pregnancies and is a major cause of maternal and neonatal morbidity and mortality. Pre-eclampsia is a hypertensive pregnancy disorder characterized by superficial implantation and inadequate placental perfusion that has been linked to increased oxidative stress. Antioxidants are important to maintain cell integrity in normal pregnancies, by inhibiting peroxidation reactions, and thus protecting enzymes, proteins and cells of peroxide destruction.


REFERENCES

  1. American College of Obstetricians and Gynecologists. Clinical management guidelines for obstetrician-gynecologists: diagnosis and management of preeclampsia and eclampsia: ACOG practice bulletin no. 33. Obstet. Gynecol 2002;99:159- 61.

  2. Sladek SM, Magness RR, Conrad KP. Nitric oxide and pregnancy. Am J Physiol 1997;272:R441-63.

  3. Khalil RA, Granger JP. Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models. Am J Physiol Regul Integr Comp Physiol 2002;283:R29-45.

  4. Paul DS. Elevated asymmetric dimethylarginine concentrations precede clinical preeclampsia, but not pregnancies with small-for-gestational-age infants Am J Obstet Gynecol 2008;198:112.e1-112.e7.

  5. Fangxian L. The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice. Am J Obstet Gynecol 2007;396e1-396e7.

  6. Vaughn CJ, Delanty N. Hypertensive emergencies. Lancet 2000;356:411-7.

  7. Aggarwal M. Hypertensive crisis: Hypertensive emergencies and urgencies. Cardiol Clin 2006;24:135-46.

  8. Caren GS. Hypertension in pregnancy. Endocrinol Metab Clin N Am 2006;35:157-71.

  9. Seongho R. Increased leukocyte adhesion to vascular endothelium in preeclampsia is inhibited by antioxidants. Am J Obstet Gynecol 2007;196:400.e1-400.e8.

  10. Cooke JP. Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol 2000;20:2032-37.

  11. Cooke JP. Asymmetrical dimethylarginine: the Upper marker? Circulation 2004; 109:1813-8.

  12. Holden DP, Fickling SA, Whitley GS, Nussey SS. Plasma concentrations of asymmetric dimethylarginine, a natural inhibitor of nitric oxide synthase, in normal pregnancy and preeclampsia. Am J Obstet Gynecol 1998;178:551-6.

  13. Pettersson A, Hedner T, Milsom I. Increased circulating concentrations of asymmetric dimethyl arginine (ADMA), an endogenous inhibitor of nitric oxide synthesis, in preeclampsia. Acta Obstet Gynecol Scand 1998;77:808-13.

  14. Savvidou MD, Hingorani AD, Tsikas D, Frolich JC, Vallance P, Nicolaides KH. Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop preeclampsia. Lancet 2003;361:1511-7.

  15. Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672-83.

  16. Cooke JP. NO and angiogenesis. Atheroscler Suppl 2003;4:53-60.

  17. Fukumura D, Gohongi T, Kadambi A, et al. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci USA 2001;98:2604-9.

  18. Teerlink T, Nijveldt RJ, de Jong S, van Leeuwen PA. Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. Anal Biochem 2002;303:131-7.

  19. Arun J. Antioxidants and the Prevention of Preeclampsia -Unresolved Issues. N Engl J Med 2005;354(17):1841-43.

  20. Carbonne B. Successful pregnancy with the use of nitric oxide donors and heparin after recurrent severe preeclampsia in a woman with scleroderma. Am J Obstet Gynecol 2007;e6- e7.

  21. Chappell LC, Seed PT, Briley AL, et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomized trial. Lancet 1999;354:810-6.

  22. Beazley D, Ahokas R, Livingston J, Griggs M, Sibai BM. Vitamin C and E supplementation in women at high risk for preeclampsia: a double-blind, placebo-controlled trial. Am J Obstet Gynecol 2005;192:520-1.

  23. Poston L, Briley AL, Seed PT, Kelly FJ, Shennan AH. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomized placebo-controlled trial. Lancet; 2006;367:1145-54.

  24. Subhasis B. Is vitamin E a safe prophylaxis for preeclampsia? Am J Obstet Gynecol 2006;194:1228-33.




2020     |     www.medigraphic.com